Karelizumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Karelizumab, covering 2024-10-15 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer [Phase 2]